Heparin-binding hemagglutinin induces IFN-γ + IL-2 + IL-17 + multifunctional CD4 + T cells during latent but not active tuberculosis disease

Clinical and Vaccine Immunology

Volumn 19, Issue 5, 2012, Pages 746-751

  Loxton, André G ^a   Black, Gillian F ^a,b   Stanley, Kim ^a   Walzl, Gerhard ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b Sustainable Livelihoods Foundation   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; GAMMA INTERFERON; HEPARIN BINDING HEMAGGLUTININ; INTERLEUKIN 17; INTERLEUKIN 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DRUG EFFICACY; FEMALE; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRACELLULAR SPACE; LYMPHOCYTE FUNCTION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2; LATENT TUBERCULOSIS; LECTINS; MALE; MIDDLE AGED; TUBERCULIN TEST; YOUNG ADULT;

EID: 84860326718     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00047-12     Document Type: Article

References (38)

1. Annunziato F, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204:1849-1861. (Pubitemid 47240944)
2. + T cells. Blood 107:4781-4789. (Pubitemid 43882629)
3. Black GF, et al. 2001. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J. Infect. Dis. 184:322-329. (Pubitemid 32662179)
4. Darrah PA, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850. (Pubitemid 47038186)
5. Delogu G, et al. 2004. Expression and purification of recombinant methylated HBHA in Mycobacterium smegmatis. FEMS Microbiol. Lett. 239: 33-39. (Pubitemid 39296713)
6. den Boon S, et al. 2007. High prevalence of tuberculosis in previously treated patients, Cape Town, South Africa. Emerg. Infect. Dis. 13:1189-1194. (Pubitemid 47359163)
7. Dheda K, et al. 2009. Utility of quantitative T cell responses versus unstimulated IFN-γ for the diagnosis of pleural tuberculosis. Eur. Respir. J. 34:1118-1126.
8. +2 mRNA, but not transforming growth factor beta (TGF-), TGF-RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment. Clin. Vaccine Immunol. 15:1165-1170.
9. Dockrell H. 2007. Gamma interferon-key, but not sufficient for protection against TB? Microbiol. Today November 2007:172-175. (Pubitemid 350153914)
10. Fine PE. 1995. Variation in protection by BCG: Implications of and for heterologous immunity. Lancet 346:1339-1345.
11. Fine PE, Vynnycky E. 1998. The effect of heterologous immunity upon the apparent efficacy of (e.g., BCG) vaccines. Vaccine 16:1923-1928. (Pubitemid 28473936)
12. Flynn JL, Chan J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129. (Pubitemid 32368031)
13. Hoft DF, et al. 2008. A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J. Infect. Dis. 198:1491-1501.
14. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. 2000. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. U. S. A. 97:13853-13858.
15. Hougardy JM, et al. 2007. Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. PLoS One 2:e926.
16. Huang D, et al. 2007. Immune gene networks of mycobacterial vaccineelicited cellular responses and immunity. J. Infect. Dis. 195:55-69. (Pubitemid 44958227)
17. Jacobsen M, et al. 2007. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J. Mol. Med. 85:613-621. (Pubitemid 46876510)
18. Kritzinger FE, et al. 2009. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop. Med. Int. Health 14:136-142.
19. Locht C, Hougardy JM, Rouanet C, Place S, Mascart F. 2006. Heparinbinding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberculosis (Edinb.) 86:303-309.
20. Masungi C, et al. 2002. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J. Infect. Dis. 185:513-520. (Pubitemid 34142814)
21. Mistry R, et al. 2007. Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J. Infect. Dis. 195:357-365. (Pubitemid 46146113)
22. Mittrucker HW, et al. 2007. Poor correlation between BCG vaccinationinduced T cell responses and protection against tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 104:12434-12439.
23. Moller M, et al. 2007. Host susceptibility to tuberculosis: CARD15 polymorphisms in a South African population. Mol. Cell Probes. 21:148-151. (Pubitemid 46091836)
24. Moller M, et al. 2009. Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population. Tuberculosis (Edinb.) 89:189-194.
25. + multifunctional memory T cells coexpress GM-CSF. Cytokine 43:143-148.
26. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. 2007. T-cell assays for the diagnosis of latent tuberculosis infection: Moving the research agenda forward. Lancet Infect. Dis. 7:428-438. (Pubitemid 46779096)
27. Pai M, O'Brien R. 2008. New diagnostics for latent and active tuberculosis: State of the art and future prospects. Semin. Respir. Crit. Care Med. 29:560-568.
28. Pai M, Zwerling A, Menzies D. 2008. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann. Intern. Med. 149:177-184.
29. Pethe K, et al. 2001. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 412:190-194. (Pubitemid 32674716)
30. Qiu L, et al. 2008. Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1α, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFNβ, TIM1, and TLR2 but low antigen-specific cellular responses. J. Infect. Dis. 198:1514-1519.
31. Roberts T, Beyers N, Aguirre A, Walzl G. 2007. Immunosuppression during active tuberculosis is characterized by decreased interferongamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J. Infect. Dis. 195:870-878. (Pubitemid 46363933)
32. Savolainen L, et al. 2008. Pilot study of diagnostic potential of the Mycobacterium tuberculosis recombinant HBHA protein in a vaccinated population in Finland. PLoS One 3:e3272.
33. +T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 180:1962-1970.
34. Soares AP, et al. 2008. Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 180:3569-3577.
35. Stop TB Partnership. 2008. TB vaccines pipeline. http://www.stoptb org/assets/documents/global/retooling/StopTB%202008%20Vaccines %20Pipeline%20March%2008.pdf.
36. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. 2009. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol. 39:723-729.
37. + Mycobacterium bovis BCG and modified vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis. Infect. Immun. 77:622-631.
38. Veerapathran A, et al. 2008. T-cell assays for tuberculosis infection: Deriving cut-offs for conversions using reproducibility data. PLoS One 3:e1850.